T&R Biofab Co. Ltd (246710) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, T&R Biofab Co. Ltd (246710) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.53 Million ≈ $11.88K USD) by net assets (₩11.31 Billion ≈ $7.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see T&R Biofab Co. Ltd (246710) market capitalisation for the company's overall valuation and market capitalisation.

T&R Biofab Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how T&R Biofab Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

T&R Biofab Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of T&R Biofab Co. Ltd ranked by their cash flow conversion efficiency. Explore 246710 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
COLUMBUS ENERGY S.A. ZY 7 F:0Q8	0.387x
Doxa AB ST:DOXA	0.055x
INFOvine co. Ltd KQ:115310	0.021x
PB Bankshares Inc NASDAQ:PBBK	0.015x
Dae Won Chem KO:024890	-0.022x
Yandal Resources Ltd AU:YRL	-1.103x
Genie Music Corporation KQ:043610	0.050x
Whitbread PLC LSE:WTB	0.105x

Annual Cash Flow Conversion Efficiency for T&R Biofab Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of T&R Biofab Co. Ltd from 2015 to 2024. View today's stock price for T&R Biofab Co. Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.21 Billion ≈ $16.41 Million	₩-11.73 Billion ≈ $-7.95 Million	-0.485x	-117.11%
2023-12-31	₩31.20 Billion ≈ $21.14 Million	₩-6.96 Billion ≈ $-4.72 Million	-0.223x	-48.88%
2022-12-31	₩39.26 Billion ≈ $26.61 Million	₩-5.89 Billion ≈ $-3.99 Million	-0.150x	+17.34%
2021-12-31	₩41.69 Billion ≈ $28.25 Million	₩-7.56 Billion ≈ $-5.12 Million	-0.181x	+0.27%
2020-12-31	₩46.05 Billion ≈ $31.21 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.182x	+12.97%
2019-12-31	₩24.76 Billion ≈ $16.78 Million	₩-5.17 Billion ≈ $-3.51 Million	-0.209x	-11.74%
2018-12-31	₩30.27 Billion ≈ $20.51 Million	₩-5.66 Billion ≈ $-3.84 Million	-0.187x	+54.45%
2017-12-31	₩9.07 Billion ≈ $6.15 Million	₩-3.72 Billion ≈ $-2.52 Million	-0.411x	-40.25%
2016-12-31	₩8.85 Billion ≈ $6.00 Million	₩-2.59 Billion ≈ $-1.76 Million	-0.293x	+0.24%
2015-12-31	₩3.58 Billion ≈ $2.42 Million	₩-1.05 Billion ≈ $-710.94K	-0.293x	--

About T&R Biofab Co. Ltd

KQ:246710 Korea Medical Devices

Market Cap

$47.03 Million

₩69.40 Billion KRW

Market Cap Rank

#22220 Global

#1401 in Korea

Share Price

₩2275.00

Change (1 day)

+0.22%

52-Week Range

₩1194.00 - ₩4535.00

All Time High

₩44150.00